The role of miR-150 in normal and malignant hematopoiesis

被引:100
作者
He, Y. [1 ]
Jiang, X. [1 ,2 ]
Chen, J. [1 ,2 ]
机构
[1] Univ Chicago, Comm Canc Biol, Chicago, IL 60637 USA
[2] Univ Chicago, Dept Med, Hematol Oncol Sect, Chicago, IL 60637 USA
基金
美国国家卫生研究院;
关键词
miR-150; hematopoiesis; hematopoietic malignancies; expression profiles; gene regulation; target genes; B-CELL DEVELOPMENT; C-MYB; MICRORNA EXPRESSION; MEDIATED CONTROL; MLL; LEUKEMIA; IDENTIFICATION; LYMPHOMA; LINEAGE; DIFFERENTIATION;
D O I
10.1038/onc.2013.346
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
MicroRNAs are a class of small non-coding RNAs that have been implicated to mediate gene regulation in virtually all important biological processes. Recently there is accumulating evidence showing that miR-150 has essential regulatory roles in both normal and malignant hematopoiesis and holds great potential as a therapeutic target in treating various types of hematopoietic malignancies. The purpose of this review is to summarize our current knowledge about the expression patterns, biological functions and regulatory mechanisms of miR-150 in normal and malignant hematopoiesis, and to highlight the important questions to be answered in this burgeoning field.
引用
收藏
页码:3887 / 3893
页数:7
相关论文
共 67 条
  • [51] c-Myb is critical for B cell development and maintenance of follicular B cells
    Thomas, MD
    Kremer, CS
    Ravichandran, KS
    Rajewsky, K
    Bender, TP
    [J]. IMMUNITY, 2005, 23 (03) : 275 - 286
  • [52] Coordination of erythropoiesis by the transcription factor c-Myb
    Vegiopoulos, Alexandros
    Garcia, Paloma
    Emambokus, Nikla
    Frampton, Jon
    [J]. BLOOD, 2006, 107 (12) : 4703 - 4710
  • [53] Myc activates telomerase
    Wang, J
    Xie, LY
    Allan, S
    Beach, D
    Hannon, GJ
    [J]. GENES & DEVELOPMENT, 1998, 12 (12) : 1769 - 1774
  • [54] miRNA analysis in B-cell chronic lymphocytic leukaemia:: proliferation centres characterized by low miR-150 and high BIC/milk-155 expression
    Wang, M.
    Tan, L. P.
    Dijkstra, M. K.
    van Lom, K.
    Robertus, J-L
    Harms, G.
    Blokzijl, T.
    Kooistra, K.
    van t'Veer, M. B.
    Rosati, S.
    Visser, L.
    Jongen-Lavrencic, M.
    Kluin, P. M.
    van den Berg, A.
    [J]. JOURNAL OF PATHOLOGY, 2008, 215 (01) : 13 - 20
  • [55] Cancer Therapy-Induced Residual Bone Marrow Injury: Mechanisms of Induction and Implication for Therapy
    Wang, Yong
    Probin, Virginia
    Zhou, Daohong
    [J]. CURRENT CANCER THERAPY REVIEWS, 2006, 2 (03) : 271 - 279
  • [56] MicroRNAs expression signatures are associated with lineage and survival in acute leukemias
    Wang, Yungui
    Li, Zejuan
    He, Chunjiang
    Wang, Dongmei
    Yuan, Xianggui
    Chen, Jianjun
    Jin, Jie
    [J]. BLOOD CELLS MOLECULES AND DISEASES, 2010, 44 (03) : 191 - 197
  • [57] The role of microRNA-150 as a tumor suppressor in malignant lymphoma
    Watanabe, A.
    Tagawa, H.
    Yamashita, J.
    Teshima, K.
    Nara, M.
    Iwamoto, K.
    Kume, M.
    Kameoka, Y.
    Takahashi, N.
    Nakagawa, T.
    Shimizu, N.
    Sawada, K.
    [J]. LEUKEMIA, 2011, 25 (08) : 1324 - 1334
  • [58] MiR-150 controls B cell differentiation by targeting the transcription factor c-myb
    Xiao, Changchun
    Calado, Dinis Pedro
    Galler, Gunther
    Thai, To-Ha
    Patterson, Heide Christine
    Wang, Jing
    Rajewsky, Nikolaus
    Bender, Timothy P.
    Rajewsky, Klaus
    [J]. CELL, 2007, 131 (01) : 146 - 159
  • [59] MicroRNA Control in the Immune System: Basic Principles
    Xiao, Changchun
    Rajewsky, Klaus
    [J]. CELL, 2009, 136 (01) : 26 - 36
  • [60] Xu Ling, 2011, Zhonghua Xue Ye Xue Za Zhi, V32, P178